Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of Celivarone at 50, 100 or 300 mg OD With Amiodarone as Calibrator for the Prevention of ICD Interventions or Death

NCT00993382 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00993382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00993382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of Celivarone at 50, 100 or 300 mg OD With Amiodarone as Calibrator for the Prevention of ICD Interventions or Death
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2009
Completion date
May 31, 2011
Enrollment
486 (actual)
Sites
151

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmia prophylaxis, ventricular arrhythmia